These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28 related articles for article (PubMed ID: 12320371)
1. Mifepristone Paternalism at the FDA. Paradise J J Law Med Ethics; 2023; 51(3):554-559. PubMed ID: 38088593 [TBL] [Abstract][Full Text] [Related]
2. [Population Council responsible for RU486 clinical trials in USA]. Aguillaume CJ Ref Gynecol Obstet; 1993 Apr; 1(4):392. PubMed ID: 12288154 [TBL] [Abstract][Full Text] [Related]
3. Introduction of RU 486 in the USA: obstacles and opportunities. Thoss E Plan Parent Eur; 1993 Oct; 22(3):18-9. PubMed ID: 12288950 [TBL] [Abstract][Full Text] [Related]
5. The political challenges and educational opportunities around very early abortion. Saul R Guttmacher Rep Public Policy; 1999 Feb; 2(1):5-7. PubMed ID: 12321968 [TBL] [Abstract][Full Text] [Related]
6. Contraceptive research: still inadequate after all these years? Diconsiglio JM Family Plan World; 1992; 2(6):14. PubMed ID: 12344623 [TBL] [Abstract][Full Text] [Related]
7. Scientists change the face of debate with RU-486 decision. Abortion issues. Sex Wkly Plus; 1996; (Sample No):7-8. PubMed ID: 12320371 [TBL] [Abstract][Full Text] [Related]
11. [RU 486--death hides behind this formula]. von Brauchitsch I Wien Med Wochenschr; 1992; (6-7):XLIV-XLVII. PubMed ID: 1514296 [TBL] [Abstract][Full Text] [Related]
12. RU 486: how abortion politics have impacted on a potentially useful drug of broad medical application. Regelson W Perspect Biol Med; 1992; 35(3):330-8. PubMed ID: 1501996 [TBL] [Abstract][Full Text] [Related]